Fennec Pharmaceuticals (FENC) Long-Term Debt Issuances (2022)
Fennec Pharmaceuticals posted quarterly Long-Term Debt Issuances of -$65000.0 for Q4 2022.
Fennec Pharmaceuticals (FENC) has 1 years of Long-Term Debt Issuances data on file, last reported at -$65000.0 in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to -$65000.0; the trailing twelve-month figure through Dec 2022 stood at -$65000.0 (changed N/A YoY), and the FY2023 full-year result was $5.0 million, down 79.96% from the prior year.
- Long-Term Debt Issuances for Q4 2022 stood at -$65000.0.
- Across five years, Long-Term Debt Issuances topped out at -$65000.0 in Q4 2022 and bottomed at -$65000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -65,000.00 |
| Dec 31, 2022 | -65,000.00 |